Chronic rhinosinusitis (CRS) is characterized by chronic inflammation of the sinonasal mucosa that persists for at least 12 weeks. [1] [2] [3] Despite the high prevalence and effect on quality of life, the cause and pathogenesis that underpin inflammation in patients with CRS are not well understood. 4, 5 Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a prominent type 2 infiltrate with increases numbers of eosinophils, but more recent evidence suggests that there is also B-cell dysregulation, as evidenced by plasma cell proliferation, increased antibody levels, increased local class-switching, and the presence of a multitude of autoantibodies. [6] [7] [8] [9] [10] [11] However, it remains unknown whether this prominent antibody response plays a role in the barrier dysfunction and pathogenic inflammation associated with CRS. 12 Because excessive antibody-mediated complement activation is frequently a hallmark for a pathologic autoantibody response, we sought to investigate whether evidence for classical pathway activation could be found in patients with CRSwNP. The complement system represents a major effector mechanism linking the adaptive and innate immune responses. However, the complement system has 3 described routes of activation: the classical, alternative, and lectin pathways. 13 All 3 pathways of activation eventually lead to the formation of C3 convertases that cleave C3 to C3a and C3b and initiate a cascade ending with the formation of C5b-9 (terminal complement complex or membrane attack complex that induces cell lysis in nonnucleated cells and can be detected by ELISA and immunohistochemistry; Fig 1) . 13, 14 The lectin pathway is initiated by activation of lectin proteins, including mannose-binding lectin and ficolins, on their binding to pathogen-associated molecular patterns. Both the classical and lectin pathways result in activation of C4 and generate the complement split product C4d. 15 C4d rapidly forms a covalent bond with any nearby protein or carbohydrate within microseconds, and thus it binds in proximity with the site of activation. 15 Like C5b-9, C4d can also be detected by means of ELISA and immunohistochemistry. The classical pathway is initiated by binding of C1q to antigen-antibody complexes, which leads to conformational changes in the C1q molecule, which releases C1r and C1s that covalently bind to the C1 inhibitor (C1inh). The soluble C1rs-C1inh complex can be detected by means of ELISA and is highly specific for activation of the classical pathway. 16 In contrast, the alternative pathway is initiated by the spontaneous hydrolysis of C3, C3(H 2 O), and does not involve the C1 or C4 molecules.
Although complement is best known for its role in clearing invading microorganisms through targeted lysis, there is growing evidence for a pathogenic role in transplant rejection, cancer, allergic inflammatory diseases, asthma, and autoimmune disorders. 17, 18 In these conditions there is either an excessive activation or an inadequate dampening of complement activation that exacerbates inflammatory cell infiltration and tissue damage. 19 Complement deposition is well described in patients with autoimmune diseases, in whom it is deposited in the glomerular basement membrane of kidneys, as seen in patients with systemic lupus erythematosus (SLE) and cryoglobulinemia. 17, 20 Separately, complement deposition is also described in the thyroid follicular basement membranes of patients with Hashimoto thyroiditis and Graves disease 21 and skin of patients with autoimmune blistering diseases, such as bullous pemphigoid, epidermolysis bullosa acquisita, and mucous membrane pemphigoid. [22] [23] [24] In patients with these skin diseases, the autoantigens are involved in cell-cell or cell-matrix adhesion in the basement membrane of the skin.
In the present study we evaluated the complement activation products C1rs-C1inh, C4d, C5b-9, and C5a to elucidate the mechanisms of complement activation in CRS. We further explore the relationship of patients with these complement activation products and the previously described phenomena of eosinophilia and anti-double-stranded DNA (dsDNA) autoantibody responses observed in tissue of patients with CRSwNP.
METHODS

Patients and tissue sample collection
Patients with CRS and control subjects without CRS were recruited from the Otolaryngology and Allergy-Immunology clinics at Northwestern Medicine. In patients with CRS, uncinate tissue (UT) and nasal polyps (NPs) were obtained during routine functional endoscopic sinus surgery. Patients with CRS met the criteria for CRS, as defined by the American Academy of Otolaryngology-Head and Neck Surgery Chronic Rhinosinusitis Task Force. 25 Tissue samples from control subjects without CRS were obtained during endoscopic skull-based tumor excisions, intranasal procedures for obstructive sleep apnea, or approaches to the orbit. Details of subjects' characteristics and specimens analyzed are shown in Table I . All subjects provided informed consent, and the study was approved by the Institutional Review Board of Northwestern University Feinberg School of Medicine.
Measurement of complement components C5b-9, C4d, C1, and C5a
Homogenates from freshly obtained sinus tissue specimens were prepared, as previously described. 26 Homogenates were analyzed for C5b-9, C4d, and C5a by using ELISA kits (Quidel, San Diego, Calif, and Abcam, Cambridge, Mass, respectively), according to the manufacturer's instructions. The activated C1 neoepitope C1rs-C1inh was measured with a sandwich ELISA, as previously described. 16 Specifically, microtiter plates were coated overnight with mouse anti-human activated C1inh mAb (Kok-12; Sanquin Blood Supply Foundation, Amsterdam, The Netherlands), and samples and control tissue extracts were incubated on the plates, washed, and further incubated with a cocktail of goat anti-human C1s and anti-C1r secondary antibodies (Quidel and Nordic immunology, Susteren, The Netherlands, respectively). Finally, complexes were detected with mouse anti-goat IgG-horseradish peroxidase (HRP; Jackson ImmunoResearch, West Grove, Pa). Human serum activated with heat-aggregated human IgG (Sigma, St Louis, Mo) was used as a standard and was defined to contain 1000 AU/mL. 16 All ELISA results were further normalized to the total protein measured in the tissue homogenate, as previously described. 6 The sensitivity limit was 3.7 ng/mL for C5b-9, 1 ng/mL for C4d, 0.12 AU/mL for activated C1, and 31 pg/mL for C5a, respectively. For concentrations less than the limit of detection, we assigned a value of zero for analysis. In instances in which data were presented on a log scale, a value corresponding to 1:10 of the limit of detection was used. Santa Cruz Biotechnology) followed by Alexa Fluor 647-conjugated donkey anti-mouse immunoglobulin (Jackson ImmunoResearch) and by rabbit polyclonal anti-human C4d (Abcam) followed by rhodamine (TRITC)-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch) or rabbit anti-human laminin (Rabbit polyclonal; Abcam), followed by Alexa Fluor 488-conjugated donkey anti-rabbit IgG (Invitrogen, Carlsbad, Calif). Spectral imaging of C5b-9, C4d, and/or laminin expression was performed on a Nikon A1R laser scanning confocal microscope equipped with a 320, 340, or 3100 objective and Nikon Elements Software (Nikon, Tokyo, Japan). For the 3100 objective, 4-color (DAPI, Alexa Fluor 488, TRITC, and Alexa Fluor 647) image stacks containing 20 to 40 sections in the Z plane in 0.5-mm steps were acquired and deconvolved by using softWoRx software (Applied Precision, Mississauga, Ontario, Canada) on a DeltaVision inverted microscope. Wholetissue section images were made by stitching 320 images taken from an entire tissue section. Specific signal was defined by imaging control slides without primary antibody to define background autofluorescence. Semiquantitative analysis of the percentage of epithelium lined with complement was determined by using the freehand line-measuring tool in ImageJ software (National Institutes of Health, Bethesda, Md). 27 
Measurement of antibody isotypes
Antibody levels were measured in NP tissue lysates by using the human immunoglobulin isotyping multiplex kit, according to the manufacturer's instructions (EMD Millipore, Billerica, Mass). Total immunoglobulin levels were calculated by adding the amount of all isotypes quantified on the Luminex 200 instrument (Thermo Fisher Scientific, Waltham, Mass). All results were normalized to total protein measured in the tissue homogenate, as previously described. 6 Antibody purification from serum and tissue extracts Antibodies were extracted with Pierce Protein A/G agarose beads (Thermo Fisher Scientific), according to the manufacturer's instructions. Protein A/G specifically bind to human antibodies of most isotypes, especially IgG but not IgD. 28 In brief, 300 mL of serum or polyp extract was added to 200 mL of agarose beads and incubated overnight at 48C on rotator. Beads were washed with Triton and eluted with elution buffer. Purified antibodies were buffer exchanged into PBS by using Zeba Spin Desalting Columns (Thermo Fisher Scientific). Purified antibodies were characterized by means of SDS-PAGE electrophoresis, followed by Coomassie blue staining. Antibody concentration was measured with a NanoDrop 1000 (Thermo Fisher Scientific) and diluted in PBS according to a concentration of 5 mg/mL with PBS.
Anti-Matrigel ELISA
Matrigel ELISAwas adapted from Orjuela et al. 29 Microtiter 96-well plates were coated with 50 mL of 500 mg/mL Matrigel matrix (BD Biosciences, San The complement activation pathway. The 3 major pathways of complement activation, classical, lectin, and alternative, all lead to formation of C3 convertases, which lead to generation of the anaphylatoxins C3a and C5a and formation of the lytic membrane attack complex (C5b-9). We evaluated the complement activation neoepitopes highlighted by the boxes. Anaphylatoxin C5a was also evaluated. Dotted arrows indicate enzymatic processes. MASP, MBL-associated serine protease; MBL, mannose-binding lectin.
14 Jose, Calif) in cold PBS and incubated overnight at 48C. The plates were washed and blocked with 200 mL of PBS containing 3% BSA for 1 hour at room temperature. After blocking, the plates were washed, and 50 mL of 5 mg/mL of purified antibodies was added to the wells and incubated at 378C for 1 hour. The plates were then washed, and bound antibodies were detected with a cocktail of HRP-conjugated goat anti-human IgM and HRPconjugated goat anti-human IgG (Bethyl Laboratories, Montgomery, Tex). All samples were run on the same day and on the same plate to ensure comparable OD 450 values of measured samples.
Statistical analysis
All data are reported as means 6 SEMs, and analyses were done with GraphPad Prism, version 6.0d, software (GraphPad Software, San Diego, Calif). Differences among groups were analyzed by using the 1-way ANOVA Kruskal-Wallis test, with a Dunn correction for multiple comparisons. Correlations were assessed by using a nonparametric Spearman rank correlation coefficient. A P value of less than .05 was considered significant.
For comparison of clinical and demographic factors associated with high and low complement activation, the population was divided into tertiles. The top tertile was compared with the bottom tertile by using x 2 contingency tables for categorical variables and t tests for continuous variables.
RESULTS
Complement was activated in NP tissue
UTs were collected from 12 control subjects, 24 patients with chronic sinusitis without nasal polyps (CRSsNP), and 27 patients with CRSwNP, and NP tissues were collected from 55 patients with CRSwNP. We first assessed formation of the terminal complement complex by measuring C5b-9 levels. We found that complement C5b-9 levels were increased in NP tissue compared with UT from patients with CRSwNP and those with CRSsNP (P < .0001 and P < .001, respectively; Fig 2, A) .
We next quantified C4d in the same sinonasal tissues extracts. C4d levels were also increased in NP tissue compared with those in UT from patients with CRSwNP, patients with CRSsNP, and control subjects (P 5 .0003, P 5 .0106, and P 5 .0001, respectively; Fig 2, B) .
Despite common use of C4d as a surrogate marker for antibody-mediated tissue rejection, C4d actually indicates that complement activation was triggered by either the classical or lectin pathways. Therefore to further resolve whether the complement activation occurred through the classical pathway, we analyzed activation of C1 by measuring the complex containing C1r-C1s and C1inh (C1rs-C1inh). Significantly increased levels of C1rs-C1inh complexes were found in NP tissue compared with those in UT from patients with CRSsNP and control subjects (P 5 .0199 and P 5 .0027, respectively; Fig 2, C) . In addition, levels of complement components C5b-9, C4d, and C1rs-C1inh complexes in sinonasal tissue were significantly correlated (see Fig E1 in this article's Online Repository at www.jacionline. org) in these homogenates. Together, these findings suggest that total and classical pathway-mediated complement activation occurred at significantly higher levels in NP tissue. The patients in the top tertile of C1rs-C1inh-, C4d-, and C5b-9-expressing polyps were compared with those in the bottom tertile in polyp tissue to further evaluate the association of these complement products with demographic and clinical factors prospectively collected on patients with CRSwNP. We found asthma was weakly associated with low C1rs-C1inh and C4d levels, but otherwise, no significant associations were found with age, sex, radiographic severity, medication use, aspirin-exacerbated respiratory disease (AERD), or history of sinus surgery (see Table E1 in this article's Online Repository at www.jacionline.org). Complement was linearly deposited along the epithelial basement membrane of polyp tissue
Because both C5b-9 and C4d levels were increased in polyp tissue (Fig 2) , we next investigated where complement was being activated. In contrast to C5b-9, which exists as soluble and membrane-associated complexes, 30 C4d is surface bound and found in close proximity to the site of activation. 15 Laminin, a component of the basement membrane, was also used to visualize the basement membrane. Immunofluorescent imaging revealed that both C5b-9 and C4d were linearly deposited along the epithelial basement membrane (Fig 3) and along most glandular epithelium (data not shown). Microscopically, C5b-9 and C4d were located on the basal side of laminin, with C4d being slightly more diffusely deposited (Fig 3) . The percentage of epithelium lined with C5b-9 was analyzed by using stitched images from sectioned tissue to evaluate the extent of epithelial basement membrane complement deposition. In NP tissue 87% of the epithelium was lined with C5b-9, whereas UT from patients with CRSsNP and control UT had significantly lower subbasement membrane complement deposition (49%, P < .05 and 16%, P < .001, respectively; Fig 4) . Together, these findings suggest that the majority of complement was being activated and deposited in the vicinity of the epithelial basement membrane.
IgM was most correlated with complement activation
Because the above results indicated that complement activation in NPs appeared to occur mainly through the classical pathway, we further tested the hypothesis that our previously reported local increases in immunoglobulin levels in NPs were associated with complement activation. NP tissue homogenates were analyzed by using the human immunoglobulin isotyping multiplex kit to quantitate IgM, IgG 1 , IgG 2 , IgG 3 , IgG 4 , and IgA. Only the classical pathway-specific activation product C1rs-C1inh levels were significantly correlated with total immunoglobulin (P 5 .0097, Spearman r 5 0.35); total IgM (P < .0001, Spearman r 5 0.54); total IgG 3 , IgG 1 , and IgG 2 (P 5 .045, Spearman r 5 0.24; P 5.021, Spearman r 5 0.27; and P 5.0008, Spearman r 5 0.39, respectively; Fig 5) ; and total IgA (P <.0076, Spearman r 5 0.31; data not shown). No significant correlations were detected between C4d and C5b-9 levels and individual immunoglobulin levels. These data might suggest that the locally increased levels of complement-fixing antibodies might play a significant role in activating the classical pathway in patients with CRSwNP.
Relationship with anaphylatoxin C5a, ECP, and antidsDNA
Anaphylatoxins play a critical role in supporting inflammation and activation of cells that express anaphylatoxin receptors. Unlike C5b-9 and C4d, which were previously analyzed, anaphylatoxins are soluble proteins that are rapidly cleared from the circulation in vivo. 31, 32 Because C5a is highly unstable and degraded quickly into C5a des-Arg, the ELISA used measures both C5a and C5a des-Arg. Although the des-Arg form of C5a is more stable, its serum half-life is still only about 2 minutes. 32 Thus we interpret anaphylatoxins as evidence for ongoing complement activation at the time of sample acquisition during surgery. Although increased levels of C5a were detected in NP tissue compared with UT, the differences were not statistically significant (Fig 6, A) . However, when correlations between levels of C5a and the other complement activation products were investigated, we found only C1rs-C1inh levels were significantly correlated with C5a levels (Fig 6, B-D) , suggesting that ongoing complement activation was best correlated with initiation of the classical pathway.
Further analysis was performed to evaluate the relationship of our complement findings with other well-characterized immunologic features of CRSwNP, namely the pronounced type 2 inflammation with eosinophilia 33 and increased anti-dsDNA IgG antibodies.
6,9 Therefore we correlated tissue ECP and antidsDNA IgG levels with C1rs-C1inh, C4d, C5b-9, and C5a levels. The complement activation products all had weak but highly significantly correlations with ECP and anti-dsDNA IgG levels, except for C5a, levels of which were not significantly correlated with ECP or anti-dsDNA IgG levels (Fig 6, E) . However, because of limitations in the availability of tissue homogenate, we were unable to analyze all the specimens for C5a, which might have affected the power to detect a significant association. Levels of complement activation products C5b-9, C4d, and C1rs-C1inh were increased in NPs compared with UT. Tissue homogenates were tested by means of ELISA, and levels were normalized to total protein for C5b-9 (A), C4d (B), and C1rs-C1inh (C). Data represent means 6 SEMs. *P < .05, **P < .01, ***P < .001, and ****P < .0001, Kruskal-Wallis test.
Increased levels of anti-basement membrane antibodies in polyp tissue
To further understand why complement was activated and deposited at the basement membrane, we tested the hypothesis that there was local autoreactivity against basement membrane components, as previously found in a subset of patients with SLE. 34 Basement membrane reactivity was assessed by using an ELISA to detect anti-Matrigel matrix antibodies. 29 Matrigel matrix is a reconstituted basement membrane preparation that is extracted from the Engelbreth-Holm-Swarm mouse sarcoma, a tumor rich in extracellular matrix protein. Antibodies were purified from NP tissue extracts and compared with serum from the same patients with CRSwNP along with a random set of serum from control subjects. Total tissue immunoglobulin levels from control subjects were low, and insufficient immunoglobulin was isolated to perform this analysis. Significant and strikingly higher concentrations of anti-Matrigel matrix IgG and IgM antibodies were detected in NP extracts compared with sera from control subjects and patients with CRSwNP (P < .0001; Fig 7) . From these data, we infer that the immunoglobulins within an NP are significantly more autoreactive to basement membrane components than those in the sera of both control subjects and patients with CRSwNP.
DISCUSSION
In this study we investigated the activation and location of complement activation in tissue from patients with CRS. We demonstrated that NP tissue had increased levels of the complement activation products C4d and C1rs-C1inh compared with UT from healthy subjects and patients with CRS (Fig 2) . Although C5b-9 levels were similarly increased, differences were not significant when comparing NP tissue with control UT. In addition, these markers also correlated significantly with each other (see Fig E1) . Similar to what was previously shown by Van Zele et al, 35 we found that C5b-9 is deposited at the basement membrane of the epithelium almost universally in NP tissue, with 87% of NP epithelium lined with C5b-9. Because C5b-9 is a stable neoepitope that exists in a soluble and surface-bound form, local deposition can result from remote activation. Thus we further evaluated C4d, a product formed from the degradation of surface-bound C4b. C4b is highly reactive and binds covalently to nearby surfaces within microseconds of activation; therefore C4d is found to be in close proximity to the site of complement activation, and its covalent bond does not break spontaneously. 15 We demonstrated that C4d was similarly deposited along the basement membrane, suggesting that complement activation through the classical or lectin pathway occurred in the vicinity of the basement membrane (Fig 3) . Together, these findings are the first studies demonstrating that complement activation through the classical antibody-mediated pathway is increased in NP tissue. Our C4d findings also further suggest that complement activation is occurring along the epithelial basement membrane.
Given these findings, we evaluated the correlation between activation products and antibodies in NP tissue. In prior studies by Hulse et al, 7 we found locally increased levels of IgG, IgA, and IgM along with increased levels of B cells and plasmablasts in NP tissue. We found that C1rs-C1inh was significantly correlated with the complement-fixing antibody isotypes IgM and IgG 1 , IgG 2 , and IgG 3 , although to a lesser extent (Fig 5) . These data might suggest that locally increased levels of complementfixing antibodies might play a significant role in activating the classical pathway in patients with CRSwNP. Interestingly, levels of IgM, the isotype that activates complement most efficiently, 36 also best correlated with C1rs-C1inh levels (Fig 5, A) . Unlike C1rs-C1inh, C4d and C5b-9 levels were not correlated with antibody isotype levels (data not shown). We postulate that given the dynamic nature of complement activation, the long tissue halflives of these covalently bound complexes and the possibility they might be activated by the other 2 complement pathways make them less readily correlated with antibody levels.
We also considered the possibility that autoreactive antibodies could be involved in complement activation because we previously found a multitude of autoreactive antibodies, including antidsDNA antibodies and anti-nuclear antibodies, present at increased levels in NP tissue. 6 We found weak but significant correlations between anti-dsDNA IgG and C1rs-C1inh, C4d, and C5b-9 but not C5a levels (Fig 6) . We hypothesize that levels of autoantibody and complement activation products might be affected by disease flares and fluctuate in time, as previously found in patients with classic autoimmune diseases, such as SLE, 37 thus weakening intercorrelations. However, because C4d binds to surfaces close to the site of activation, we investigated the presence of anti-basement membrane autoreactive antibodies in NP tissue and compared them with serum from the same patients and control subjects. Anti-Matrigel antibodies have been studied in patients with SLE because Matrigel contains many of the constituent matrix proteins that make up basement membranes. 29 We found markedly high levels of anti-Matrigel autoreactive antibodies present in NP tissue that were not detected at higher levels systemically (Fig 7) . Another possible mechanism for basement membrane complement activation was shown by van Bruggen et al, 38 who found that anti-dsDNA or antinucleosome autoantibody immune complexes could bind to the glomerular basement membrane, whereas purified antibodies did not. They attributed this to binding between the positively charged histone moieties within the nucleosome with anionic determinants in the glomerular basement membrane. 38 These findings are reminiscent of recent studies examining serum from patients with SLE by using autoantigen microarrays. In studies by Zhen et al, 39 increased levels of antibodies binding basement membrane components (vimentin, myosin, Matrigel, laminin, and heparan sulfate) were separately clustered from antibodies against dsDNA, single-stranded DNA, and chromatin, but both were independently associated with more severe disease, suggesting that autoreactivity to basement membrane and nuclear antigens played an important role in lupus severity. We postulate that because both anti-basement membrane and anti-nuclear autoantibodies are similarly found in patients with CRSwNP at increased levels, complement activation at the basement membrane through the classical pathway can occur through similar mechanisms, as has been described in patients with SLE.
Previous studies by Schlosser et al 40 and Lane et al 41 have evaluated gene expression of complement factors in tissue from patients with CRS. They found that tissue from patients with CRSsNP had significantly higher gene expression of factor B, C3, and C5 compared with control subjects. 40 Indeed, normal nasal epithelial cells have also been shown to produce C3 locally. 41 In addition, several airway epithelial cells and cell lines upregulate the expression of C3 in response to cytokines. [42] [43] [44] [45] The study by Schlosser et al 40 also found C5b-9 deposition in the basement membrane by means of immunohistochemistry. However, in contrast to our findings, they found that C4d and C3d were deposited on the apical surface of the epithelial cells, as well as on endothelial and inflammatory cells within the submucosa. 40 These discrepancies might be due to the use of different antibodies and/or a different fixation protocol. In our prior experience nonspecific binding to cilia or mucus proteins in immunofluorescent immunohistochemistry studies of the nasal mucosa occurs frequently and requires caution when concluding ciliary protein expression. A separate study by Van Zele et al 35 found that levels of the complement anaphylatoxins C3a and C5a were significantly increased in nasal secretions from patients with CRSwNP compared with control subjects, and C5b-9 deposition was reported at the basement membrane of mucosal epithelium and blood vessels of NPs. Serum C3a and C5a levels were not increased in NPs compared with control subjects, suggesting the complement activation is a local process. 35 Our study of sinonasal tissue found nonsignificant but increased levels of tissue C5a that were positively correlated with ECP (Fig 6) . However, our study might not be adequately powered to detect differences in tissue anaphylatoxins, and nasal tissue might contain factors that rapidly degrade C5a given the labile nature of this protein.
Together, although prior studies have provided evidence that nasal tissue can produce some complement proteins and that there was evidence for ongoing complement activation in patients with CRSwNP, the mechanism of complement activation was previously unknown.
Although the effects of complement activation products on nasal epithelial cells are largely unknown, they have been studied in other epithelial cells. Insertion of C5b-9 into cell membranes will induce cell lysis of nonnucleated cells (eg, bacteria and red blood cells). 20 In nucleated cells C5b-9 is usually sublytic and instead induces cellular activation, promotion of tissue injury, or both. 46, 47 For example, C5b-9 has been shown to induce endothelial cell proliferation 48 epithelial cells. 49 Complement activation products have also been shown to promote epithelial-to-mesenchymal transition (EMT). 50 EMT is a biological process by which epithelial cells lose their cellular polarity and cell-cell adhesion to assume a mesenchymal cell phenotype. Indeed, prior work has demonstrated evidence for EMT in NP tissue. 51 Tang et al 50 have shown that C3a induces EMT through activation of the C3a receptor on tubular epithelial cells. Similar to tubular epithelial cells, nasal epithelial cells also express this receptor, 52 and thus C3a might similarly promote EMT in patients with CRSwNP. In addition, C5a has been shown to induce production of oncostatin M by macrophages. 53 We have recently shown that oncostatin M is a potent cytokine that disrupts epithelial barrier integrity in patients with CRSwNP and other type 2 inflammatory conditions. 54 Thus the activation of complement immediately below the epithelial basement membrane might promote the barrier dysfunction observed in patients with CRSwNP through multiple mechanisms.
In addition to effects on epithelial cells, complement activation products have potent proinflammatory effects on eosinophils, 55 mast cells, 56 and macrophages, 57 which have been described at increased levels in patients with CRSwNP. The anaphylatoxins in particular are powerful leukocyte chemotactic factors, can induce oxidative burst, [58] [59] [60] and can cause degranulation of mast cells. 61 Anaphylatoxin-induced histamine release by basophils and mast cells results in vasodilation. 62, 63 In the eosinophilic inflammation that typifies Western CRSwNP, C5a plays important roles in upregulating cell-adhesion molecules on eosinophils 64 and enhances degranulation. 65 We found that C5a levels were significantly correlated with the increased levels of the classical pathway activation product C1rs-C1inh and that complement activation was positively correlated with ECP levels (Fig  6) . Because anaphylatoxins, such as C5a, are unstable products and are degraded quickly, 31, 32 these results suggest ongoing complement activation was occurring through the classical pathway. Finally, the complement components C3d and iC3b, a degradation product of C5b, play important roles in antibody generation by B cells through interaction with the complement receptor C2, which forms a coreceptor complex with CD19 and CD81. These complement split products increase the strength of B-cell receptor signaling and decrease the threshold for B-cell activation. 66 Overall, we find it intriguing that autoreactive antibodies might play a role in activating complement adjacent to the basement membrane, whereas complement activation can in turn lead to the dysregulation of B cells observed in patients with CRSwNP.
In summary, we have shown that levels of the complement activation products were increased specifically in NP tissue compared with UTof patients with CRSwNP, patients with CRSsNP, and control subjects. We found that the activated complement was deposited along the basement membrane of the nasal epithelium and propose that complement might, directly or indirectly, alter epithelial barrier viability and function. Furthermore, our data strongly suggest that the classical complement pathway is a driver of complement activation in patients with CRSwNP. Local increases in IgM levels and the presence of anti-basement membrane autoreactive antibodies can initiate this process. , and C1rs-C1inh levels in sinonasal tissue correlated moderately but significantly. Correlation between C4d and C1rs-C1inh levels (A); correlation between C4d and C5b-9 levels (B); and correlation between C1rs-inh and C5b-9 levels measured in sinonasal tissue homogenates (C). Correlations were assessed by using the nonparametric Spearman rank correlation coefficient. 
